Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Postdiagnostic pretreatment risk stratification for chondrosarcoma survival using routinely available registry variables: a SEER-based temporal validation study
Related
- Explainable machine learning using pretreatment complete blood count parameters and demographic characteristics for gastric cancer risk stratification: a temporal validation study
- Pretreatment AMH–AFC stratification of poor-ovarian-response risk in young women with diminished ovarian reserve: a multicentre retrospective cohort study
- A pretreatment TNM-metabolic vulnerability score with EBV DNA adjustment for risk stratification in non-metastatic nasopharyngeal carcinoma
- Pretreatment prediction of early severe treatment-related toxicity in older patients with lung adenocarcinoma: same-center temporal validation of a risk model
- Risk stratification by circulating tumor DNA-based pretreatment genomic profile and post-operative molecular residual disease detection in resectable colorectal oligometastases: PRECISION, a prospective multicenter study
BibTeX
@article{wang2026postdiagnostic,
title = {{Postdiagnostic pretreatment risk stratification for chondrosarcoma survival using routinely available registry variables: a SEER-based temporal validation study}},
author = {Qiong Wang and Junhu Wang and Jie Wang and Wu Hu and Hongmou Zhao},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74220-0},
url = {https://www.nature.com/articles/s41598-026-74220-0},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Postdiagnostic pretreatment risk stratification for chondrosarcoma survival using routinely available registry variables: a SEER-based temporal validation study
AU - Qiong Wang
AU - Junhu Wang
AU - Jie Wang
AU - Wu Hu
AU - Hongmou Zhao
PY - 2026
DA - 2026/10/04
JO - Scientific Reports
DO - 10.1038/s41598-026-74220-0
UR - https://www.nature.com/articles/s41598-026-74220-0
SN - 2045-2322
ER -